SEC Form 4 · accession 0001127602-18-034850
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Denton
Officer — EVP and CFO
Period of report
Nov 29, 2018
Accepted (ET)
Nov 30, 2018 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 29, 2018 | S | 25,159 | $80.13 | D | 403 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.72 and $80.54 per share.